Remove 2013 Remove Competition Remove Marketing Remove Pharmacology
article thumbnail

Patents: a necessary evil?

European Pharmaceutical Review

2 Recently, the US Patent and Trademark Office (US PTO) reiterated the concern that patents have been “misused to inhibit and delay – for years and even decades – competition from generic drugs and biosimilars, denying Americans access to lower-cost drugs.” 23 April 2013. References. Why Patents Are the Lifeblood Of Biotech Companies.